Amedisys - Insider Transactions

The most recent insider transaction for Amedisys was conducted by Guidroz Allyson, who sold 374 shares on May 8, 2025 at a price of $96.00 per share.

Guidroz Allyson has sold the most AMED stock in the last 2 years, with a total value of $220,000.

The total value of insider transactions for Amedisys in the last 2 years is negative, amounting to -$220,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

Over the last 2 years, insider transactions for Amedisys have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.